Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5079833
Max Phase: Preclinical
Molecular Formula: C39H64N12O10
Molecular Weight: 861.01
Molecule Type: Unknown
Associated Items:
ID: ALA5079833
Max Phase: Preclinical
Molecular Formula: C39H64N12O10
Molecular Weight: 861.01
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
Standard InChI: InChI=1S/C39H64N12O10/c1-21(31(53)46-23(3)33(55)49-28(38(60)61)15-10-18-44-39(42)43)45-32(54)22(2)47-36(58)30(24(4)52)50-35(57)29-16-11-19-51(29)37(59)27(14-8-9-17-40)48-34(56)26(41)20-25-12-6-5-7-13-25/h5-7,12-13,21-24,26-30,52H,8-11,14-20,40-41H2,1-4H3,(H,45,54)(H,46,53)(H,47,58)(H,48,56)(H,49,55)(H,50,57)(H,60,61)(H4,42,43,44)/t21-,22-,23+,24+,26-,27-,28-,29-,30-/m0/s1
Standard InChI Key: CIKIAULSMKDPQZ-JRPWWCNASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 861.01 | Molecular Weight (Monoisotopic): 860.4868 | AlogP: -3.63 | #Rotatable Bonds: 25 |
Polar Surface Area: 366.38 | Molecular Species: ZWITTERION | HBA: 12 | HBD: 13 |
#RO5 Violations: 3 | HBA (Lipinski): 22 | HBD (Lipinski): 16 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.04 | CX Basic pKa: 11.56 | CX LogP: -5.90 | CX LogD: -8.81 |
Aromatic Rings: 1 | Heavy Atoms: 61 | QED Weighted: 0.03 | Np Likeness Score: 0.15 |
1. Gorman DM, Li XX, Lee JD, Fung JN, Cui CS, Lee HS, Rolfe BE, Woodruff TM, Clark RJ.. (2021) Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity., 64 (22.0): [PMID:34762432] [10.1021/acs.jmedchem.1c01174] |
Source(1):